Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Goldstein

Showing results (1191-1200 of 1,434) with videos related to

Pageof 144
Sort By:
Plos One|February 25, 2015
A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APPApril M Weissmiller, Orlangie Natera-Naranjo, Sol M Reyna, et al.
Pigment Cell & Melanoma Research|February 12, 2024
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentationNathaniel B Goldstein, Andrea Steel, Landon Tomb, et al.
JAMA Psychiatry|October 27, 2015
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013Deborah S Hasin, Tulshi D Saha, Bradley T Kerridge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1997
Prediction of early death in end-stage renal disease patients starting dialysisB J Barrett, P S Parfrey, J Morgan, et al.
Journal of Hepatology|October 27, 2011
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1Charles D Howell, Alexis Gorden, Kathleen A Ryan, et al.
Schizophrenia Research|January 16, 2023
Genetic insights into childhood-onset schizophrenia: The yield of clinical exome sequencingAnna Alkelai, Lior Greenbaum, Shahar Shohat, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2007
Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitorsMugdha Thakur, Iris Grossman, Douglas C McCrory, et al.
Archives of Neurology|June 15, 2011
Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialAlfred Callahan, Pierre Amarenco, Larry B Goldstein, et al.
The Journal of Clinical Psychiatry|June 24, 2016
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United StatesTulshi D Saha, Bradley T Kerridge, Risë B Goldstein, et al.
Gastroenterology|July 13, 2010
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic responseAlessandra Mangia, Alexander J Thompson, Rosanna Santoro, et al.
Pageof 144

Showing results (1191-1200 of 1,434) with videos related to

Sort By:
Pageof 144
Plos One|February 25, 2015
A γ-secretase inhibitor, but not a γ-secretase modulator, induced defects in BDNF axonal trafficking and signaling: evidence for a role for APPApril M Weissmiller, Orlangie Natera-Naranjo, Sol M Reyna, et al.
Pigment Cell & Melanoma Research|February 12, 2024
Vitiligo non-responding lesions to narrow band UVB have intriguing cellular and molecular abnormalities that may prevent epidermal repigmentationNathaniel B Goldstein, Andrea Steel, Landon Tomb, et al.
JAMA Psychiatry|October 27, 2015
Prevalence of Marijuana Use Disorders in the United States Between 2001-2002 and 2012-2013Deborah S Hasin, Tulshi D Saha, Bradley T Kerridge, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|February 1, 1997
Prediction of early death in end-stage renal disease patients starting dialysisB J Barrett, P S Parfrey, J Morgan, et al.
Journal of Hepatology|October 27, 2011
Single nucleotide polymorphism upstream of interleukin 28B associated with phase 1 and phase 2 of early viral kinetics in patients infected with HCV genotype 1Charles D Howell, Alexis Gorden, Kathleen A Ryan, et al.
Schizophrenia Research|January 16, 2023
Genetic insights into childhood-onset schizophrenia: The yield of clinical exome sequencingAnna Alkelai, Lior Greenbaum, Shahar Shohat, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics|December 20, 2007
Review of evidence for genetic testing for CYP450 polymorphisms in management of patients with nonpsychotic depression with selective serotonin reuptake inhibitorsMugdha Thakur, Iris Grossman, Douglas C McCrory, et al.
Archives of Neurology|June 15, 2011
Risk of stroke and cardiovascular events after ischemic stroke or transient ischemic attack in patients with type 2 diabetes or metabolic syndrome: secondary analysis of the Stroke Prevention by Aggressive Reduction in Cholesterol Levels (SPARCL) trialAlfred Callahan, Pierre Amarenco, Larry B Goldstein, et al.
The Journal of Clinical Psychiatry|June 24, 2016
Nonmedical Prescription Opioid Use and DSM-5 Nonmedical Prescription Opioid Use Disorder in the United StatesTulshi D Saha, Bradley T Kerridge, Risë B Goldstein, et al.
Gastroenterology|July 13, 2010
An IL28B polymorphism determines treatment response of hepatitis C virus genotype 2 or 3 patients who do not achieve a rapid virologic responseAlessandra Mangia, Alexander J Thompson, Rosanna Santoro, et al.
Pageof 144